Show simple item record

dc.contributor.authorCasadio, M.
dc.contributor.authorCardinale, V.
dc.contributor.authorKlümpen, H.-J.
dc.contributor.authorMorement, H.
dc.contributor.authorLacasta, Adelaida
dc.contributor.authorKoerkamp, B.G.
dc.contributor.authorBañales Asurmendi, Jesús María ORCID
dc.contributor.authorAlvaro, D.
dc.contributor.authorValle, J.W.
dc.contributor.authorLamarca, A.
dc.date.accessioned2022-02-10T12:03:27Z
dc.date.available2022-02-10T12:03:27Z
dc.date.issued2022-01-27
dc.identifier.citationEsmo Open 7(1) : (2022) // Article ID 100377es_ES
dc.identifier.issn2059-7029
dc.identifier.urihttp://hdl.handle.net/10810/55417
dc.description.abstractBACKGROUND: Cholangiocarcinomas (CCAs) are a rare group of malignancies characterized by dismal prognosis. There are currently no standardized guidelines for multidisciplinary teams (MDTs) in CCAs. MATERIAL AND METHODS: An online survey was built with the aim of defining the current practice of MDTs in CCAs and identifying possible areas of improvement, providing minimum standards of practice for an ideal CCA MDT. Analysis of the replies regarding current and ideal MDT practice was carried out by calculating weighted average (WA) of likelihood of every item. The survey was shared with members of the European Network for the Study of Cholangiocarcinoma and other medical centers with expertise in biliary tract cancer part of the EURO-CHOLANGIO-NET (European Cholangiocarcinoma Network: https://eurocholangionet.eu/) COST Action CA18122 initiative. RESULTS: The role of the MDT coordinator was a recognized priority in an ideal well-functioning MDT (WA 3.31/4), together with providing minimum clinical information before the meeting to secure adequate case preparation (WA 3.54/4). Optimal frequency of MDT meetings was weekly according to 76.92% of the participants; 73.06% believed that ideally all newly diagnosed patients and each new treatment should be discussed, although that happened only in less than half of the MDTs (46.15%) in current practice. Most participants stated that they always (46.15%) or often (50.00%) used guidelines, mainly international (61.00%) (European and American), followed by national/local (39.00%). We defined the ideal setup of a CCA MDT, identifying specialists whose presence is mandatory with WA >3.0 (oncologist, clinician responsible for patient's care, surgeon, diagnostic and interventional radiologist, hepatologist, pathologist, endoscopist and gastroenterologist) and those whose presence would be recommended with a WA <3.0 (palliative care, nurse, dietitian, basic researcher, psychologist and social worker). CONCLUSIONS: Our identified minimum requirements should be taken into account at the time of CCA MDT setup and quality assessment.es_ES
dc.description.sponsorshipMC participated as mentee to the Euro-Cholangio-Net Mentorship Program of EURO-CHOLANGIO-NET COST Ac- tion CA18122, as a medical resident of gastroenterology in Sapienza University of Rome. AL received funding from The Christie Charity and the European Union’s Horizon 2020 Research and Innovation Programme [grant number 825510, ESCALON]; this article/publication is based upon work from COST Action European Cholangiocarcinoma Network, supported by COST (European Cooperation in Science and Technology; www.cost.eu), a funding agency for research and innovation networks. JB was funded by Spanish Carlos III Health Institute (ISCIII) [Miguel Servet Program grant numbers CON14/00129 and CPII19/00008]; CIBERehd (ISCIII); Department of Health of the Basque Country [grant number 2017111010]; BIOEF (Basque Foun- dation for Innovation and Health Research: EiTB Maratoia BIO15/CA/016/BD); ‘Fundación Científica de la Asociación Española Contra el Cáncer’ (AECC Scientific Foundation); and the European Union’s Horizon 2020 Research and Innovation Program [grant number 825510, ESCALON].es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.relationinfo:eu-repo/grantAgreement/EC/H2020/825510es_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.subjectEuropees_ES
dc.subjectcholangiocarcinomaes_ES
dc.subjectcurrent practicees_ES
dc.subjectmultidisciplinary teames_ES
dc.subjectsurveyes_ES
dc.titleSetup of multidisciplinary team discussions for patients with cholangiocarcinoma: current practice and recommendations from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)es_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holder2022 The Authors. Published by Elsevier Ltd on behalf of Eu- ropean Society for Medical Oncology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/es_ES
dc.rights.holderAtribución-NoComercial-SinDerivadas 3.0 España*
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S2059702921003392?via%3Dihubes_ES
dc.identifier.doi10.1016/j.esmoop.2021.100377
dc.contributor.funderEuropean Commission


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

2022 The Authors. Published by Elsevier Ltd on behalf of Eu-
ropean Society for Medical Oncology. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/
Except where otherwise noted, this item's license is described as 2022 The Authors. Published by Elsevier Ltd on behalf of Eu- ropean Society for Medical Oncology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/